Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
Korean J Hepatol. 2010 Jun;16(2):187-191. Korean. Case Report.
Lee YN , Jeong SW , Lim JH , Ryu YS , Jeon SR , Kim SK , Jang JY , Kim YS , Kim BS , Roh MO .
Institute for Digestive Research, Endocrinology, Soonchunhyang University College of Medicine, Seoul, Korea.
Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea.

Combined pegylated interferon and ribavirin therapy for chronic hepatitis C infection cause a wide range of side effects, including flu-like syndrome, hematological abnormalities, cardiovascular symptoms, gastrointestinal symptoms, pulmonary dysfunction, depression, and retinopathy. Interferon-alpha has been shown to be related to the development of various autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, autoimmune thyroid disease, and type 1 diabetes mellitus (DM). Type 1 DM and thyroid disease respectively develop in 0.08~2.61% and 10~15% of patients treated with combined interferon-alpha and ribavirin for chronic hepatitis C. The coexistence of type 1 DM and autoimmune thyroiditis was rarely reported. We report a case of a 33-year-old female patient with chronic hepatitis C who simultaneously developed diabetic ketoacidosis and autoimmune thyroiditis after treatment with pegylated interferon-alpha 2b and ribavirin.

Copyright © 2019. Korean Association of Medical Journal Editors.